Elixir Pharmaceuticals: targeting molecular sources of aging.
McCarthy
Alice A
AA
D000375:Aging / Q000235:genetics* / Q000378:metabolism*; D000818:Animals; D029742:Caenorhabditis elegans Proteins; D002352:Carrier Proteins / Q000378:metabolism; D015195:Drug Design; D004345:Drug Industry / Q000639:trends; D006801:Humans; D034904:Lamin Type A / Q000235:genetics / Q000378:metabolism; D008297:Male; D017526:Receptor, IGF Type 1 / Q000378:metabolism; D011972:Receptor, Insulin / Q000378:metabolism; D037761:Sirtuins / Q000378:metabolism
D029742:Caenorhabditis elegans Proteins; D002352:Carrier Proteins; D034904:Lamin Type A; C106092:microsomal triglyceride transfer protein; C107483:DAF-2 protein, C elegans; D017526:Receptor, IGF Type 1; D011972:Receptor, Insulin; D037761:Sirtuins